PRM64 - THE NEED FOR INNOVATIVE SURVIVAL MODELLING APPROACHES IN HEALTH TECHNOLOGY ASSESSMENTS (HTA) OF EARLY-STAGE ONCOLOGY INDICATIONS

MLA

F Degener, et al. “Prm64 - the Need for Innovative Survival Modelling Approaches in Health Technology Assessments (Hta) of Early-Stage Oncology Indications.” Value in Health, vol. 21, Oct. 2018, p. S366. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0aea8dacce1639c603b3186c1d3ac93&authtype=sso&custid=ns315887.

APA

F Degener, J Maervoet, & A. Van Engen. (2018). Prm64 - the Need for Innovative Survival Modelling Approaches in Health Technology Assessments (Hta) of Early-Stage Oncology Indications. Value in Health, 21, S366.

Chicago

F Degener, J Maervoet, and A. Van Engen. 2018. “Prm64 - the Need for Innovative Survival Modelling Approaches in Health Technology Assessments (Hta) of Early-Stage Oncology Indications.” Value in Health 21 (October): S366. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d0aea8dacce1639c603b3186c1d3ac93&authtype=sso&custid=ns315887.